HUT75840A - Expression of n-terminally extended proteins in yeast - Google Patents

Expression of n-terminally extended proteins in yeast Download PDF

Info

Publication number
HUT75840A
HUT75840A HU9603476A HU9603476A HUT75840A HU T75840 A HUT75840 A HU T75840A HU 9603476 A HU9603476 A HU 9603476A HU 9603476 A HU9603476 A HU 9603476A HU T75840 A HUT75840 A HU T75840A
Authority
HU
Hungary
Prior art keywords
glu
lys
peptide
asp
ala
Prior art date
Application number
HU9603476A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9603476D0 (en
Inventor
Jakob Brandt
Thomas Borglum Kjeldsen
Knud Vad
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HU9603476D0 publication Critical patent/HU9603476D0/hu
Publication of HUT75840A publication Critical patent/HUT75840A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HU9603476A 1994-06-17 1995-06-16 Expression of n-terminally extended proteins in yeast HUT75840A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK71294 1994-06-17

Publications (2)

Publication Number Publication Date
HU9603476D0 HU9603476D0 (en) 1997-02-28
HUT75840A true HUT75840A (en) 1997-05-28

Family

ID=8096676

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603476A HUT75840A (en) 1994-06-17 1995-06-16 Expression of n-terminally extended proteins in yeast

Country Status (16)

Country Link
EP (1) EP0765395A1 (fr)
JP (1) JP3730255B2 (fr)
CN (1) CN1131312C (fr)
AU (1) AU2733595A (fr)
BR (1) BR9508053A (fr)
CA (1) CA2192943A1 (fr)
CZ (1) CZ363796A3 (fr)
FI (1) FI965030A (fr)
HU (1) HUT75840A (fr)
IL (1) IL114160A (fr)
MX (1) MX9606536A (fr)
NO (1) NO965411L (fr)
PL (1) PL317761A1 (fr)
SG (1) SG47883A1 (fr)
WO (1) WO1995035384A1 (fr)
ZA (1) ZA954983B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
ZA9610456B (en) * 1995-12-20 1997-06-20 Novo Nordisk As N-terminally extended proteins expressed in yeast
JP4341859B2 (ja) 1996-12-13 2009-10-14 ノバルティス バクシンズ アンド ダイアグノスティックス， インコーポレーテッド 酵母での異種タンパク質の発現の方法
AU7873798A (en) * 1996-12-20 1998-07-17 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
EP1049790A1 (fr) 1998-01-23 2000-11-08 Novo Nordisk A/S Procede servant a preparer des polypeptides souhaites dans de la levure
RU2002120513A (ru) 1999-12-29 2004-03-27 Ново Нордиск А/С (DK) Способ производства предшественников инсулина и аналогов предшественников инсулина с повышенным выходом ферментации у дрожжей
WO2003010185A2 (fr) * 2001-07-24 2003-02-06 Novo Nordisk A/S Procede pour produire des polypeptides acyles
US7595172B2 (en) 2001-07-24 2009-09-29 Novo Nordisk A/S Method for making acylated polypeptides
US20030082671A1 (en) 2001-07-24 2003-05-01 Thomas Hoeg-Jensen Method for making acylated polypeptides
WO2004085472A1 (fr) * 2003-03-27 2004-10-07 Novo Nordisk A/S Procede de fabrication de precurseurs de l'insuline humaine et insuline humaine
JP5697831B2 (ja) 2003-12-03 2015-04-08 ノヴォ ノルディスク アー／エス 単鎖インシュリン
EP1917363B1 (fr) 2005-08-16 2011-06-22 Novo Nordisk A/S Procede permettant de realiser des polypeptides d'insuline matures
ES2542146T3 (es) * 2006-07-31 2015-07-31 Novo Nordisk A/S Insulinas extendidas PEGiladas.
WO2008034881A1 (fr) 2006-09-22 2008-03-27 Novo Nordisk A/S Analogues de l'insuline résistants à une protéase
EP2069502B1 (fr) 2006-09-27 2014-02-26 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
ES2425413T3 (es) 2006-11-22 2013-10-15 Novo Nordisk A/S Método para preparar carboxipeptidasa activada
CN101743252A (zh) 2007-07-16 2010-06-16 诺沃-诺迪斯克有限公司 蛋白酶稳定化的、peg化的胰岛素类似物
EP2178909B1 (fr) 2007-08-13 2015-10-21 Novo Nordisk A/S Analogues de l'insuline à action rapide
EP2178912B1 (fr) 2007-08-15 2015-07-08 Novo Nordisk A/S Analogues de l'insuline comprenant un fragment acyle et alkylène glycol
JP5721432B2 (ja) 2007-08-15 2015-05-20 ノボ・ノルデイスク・エー／エス アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
JP5749155B2 (ja) 2008-03-18 2015-07-15 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化アシル化インスリンアナログ
EP2262539B1 (fr) 2008-04-01 2015-07-15 Novo Nordisk A/S Conjugués insuline-albumine
ES2440289T3 (es) 2009-06-26 2014-01-28 Novo Nordisk A/S Preparación que comprende insulina, nicotinamida y arginina
US8815541B2 (en) 2009-11-25 2014-08-26 Novo Nordisk A/S Method for making polypeptides
EP2585483A1 (fr) 2010-06-23 2013-05-01 Novo Nordisk A/S Insuline humaine contenant des liaisons disulfures supplémentaires
US8853155B2 (en) 2010-06-23 2014-10-07 Novo Nordisk A/S Insulin derivatives containing additional disulfide bonds
EP2585484A1 (fr) 2010-06-23 2013-05-01 Novo Nordisk A/S Analogues de l'insuline contenant des liaisons disulfures supplémentaires
CN103249427A (zh) 2010-12-14 2013-08-14 诺沃—诺迪斯克有限公司 速效胰岛素联合长效胰岛素
RU2013130374A (ru) 2010-12-14 2015-01-20 Ново Нордиск А/С Препарат, содержащий инсулин, никотинамид и аминокислоту
US9260503B2 (en) 2011-06-15 2016-02-16 Novo Nordisk A/S Multi-substituted insulins
WO2013186138A1 (fr) 2012-06-14 2013-12-19 Novo Nordisk A/S Préparation comprenant de l'insuline, du nicotinamide et de l'arginine
CA2890048C (fr) 2012-12-03 2022-05-03 Merck Sharp & Dohme Corp. Insuline et analogues d'insuline a base de peptide a partie terminale carboxy (ptc) o-glycosylee
EP3004156A1 (fr) 2013-06-07 2016-04-13 Novo Nordisk A/S Procédé de fabrication de polypeptides d'insuline mature
US20160376330A1 (en) 2014-02-28 2016-12-29 Novo Nordisk A/S Mating factor alpha pro-peptide variants
CN107743494B (zh) 2015-06-02 2022-04-29 诺和诺德股份有限公司 具有极性重组延伸体的胰岛素
US20180244743A1 (en) 2015-08-25 2018-08-30 Novo Nordisk A/S Novel Insulin Derivatives and the Medical Uses Hereof
EP3341403B1 (fr) 2015-08-25 2022-01-05 Novo Nordisk A/S Nouveaux dérivés d'insuline et utilisations médicales de ceux-ci
CN108026156A (zh) 2015-08-25 2018-05-11 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
WO2017202936A1 (fr) * 2016-05-24 2017-11-30 Novo Nordisk A/S Composés mic-1 et leur utilisation
BR112020002364A2 (pt) 2017-08-17 2020-09-01 Novo Nordisk A/S derivado de insulina, produto intermediário, uso de um derivado de insulina, e, métodos para o tratamento ou prevenção de diabetes, diabetes do tipo 1, diabetes do tipo 2, tolerância à glicose comprometida, hiperglicemia, dislipidemia, obesidade, síndrome metabólica, hipertensão, distúrbios cognitivos, aterosclerose, infarto do miocárdio, acidente vascular cerebral, distúrbios cardiovasculares, doença cardíaca coronariana, síndrome intestinal inflamatória, dispepsia, hipotensão ou úlceras gástricas, e para determinar a seletividade de um composto de insulina
EP3807306A4 (fr) * 2018-06-18 2022-04-06 Unichem Laboratories Limited Séquence leader pour une expression plus élevée de protéines recombinées
RS65822B1 (sr) 2019-12-11 2024-09-30 Novo Nordisk As Novi insulinski analozi i njihova upotreba
WO2023144240A1 (fr) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Dérivés d'insuline sensibles au glucose et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
US5010182A (en) * 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
CA1340772C (fr) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression et secretion de proteines heterologues dans une levure au moyen de sequences leader tronquees du facteur alpha
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DK300090D0 (da) * 1990-12-19 1990-12-19 Novo Nordisk As Fremgangsmaade til fremstilling af leadersekvenser
WO1992013951A1 (fr) * 1991-02-04 1992-08-20 The Salk Institute Biotechnology/Industrial Associates, Inc. Production de serumalbumine humaine dans des cellules de levure methylotrophique

Also Published As

Publication number Publication date
JP3730255B2 (ja) 2005-12-21
IL114160A (en) 2006-12-31
HU9603476D0 (en) 1997-02-28
ZA954983B (en) 1996-02-14
IL114160A0 (en) 1995-10-31
FI965030A0 (fi) 1996-12-16
NO965411D0 (no) 1996-12-16
SG47883A1 (en) 1998-04-17
CZ363796A3 (en) 1997-05-14
AU2733595A (en) 1996-01-15
BR9508053A (pt) 1997-08-12
CN1131312C (zh) 2003-12-17
CN1152942A (zh) 1997-06-25
EP0765395A1 (fr) 1997-04-02
CA2192943A1 (fr) 1995-12-28
JPH10501695A (ja) 1998-02-17
WO1995035384A1 (fr) 1995-12-28
MX9606536A (es) 1997-03-29
FI965030A (fi) 1997-02-14
NO965411L (no) 1997-02-14
PL317761A1 (en) 1997-04-28

Similar Documents

Publication Publication Date Title
HUT75840A (en) Expression of n-terminally extended proteins in yeast
US6500645B1 (en) N-terminally extended proteins expressed in yeast
AU693569B2 (en) Synthetic leader peptide sequences
AU660161B2 (en) A method of constructing synthetic leader sequences
JP3542604B2 (ja) Ｙａｐ３シグナルペプチドをコードするｄｎａ構築体
WO1989002463A1 (fr) Peptides guides synthetiques secretes dans des levures
JP2001527387A (ja) 合成リーダーペプチド配列
HU211600A9 (en) Yeast expressing system
EP0946735B1 (fr) Proteines a extension d'extremite n-terminal exprimees dans la levure
JP4180112B2 (ja) 酵母細胞におけるｎ末端を伸長されたタンパクの発現のためのベクター
CA2192942C (fr) Sequences de peptides leaders synthetiques
RU2167939C2 (ru) Способ продуцирования полипептида в дрожжах

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal